# PT-141 + Selank for SSRI Users: Evidence Review

slug: pt-141-selank-ssri · https://miscsubjects.com/a/pt-141-selank-ssri · tags: peptide, topic · updated 2026-07-17T02:41:10.196Z

## PT-141 (Bremelanotide) Evidence

PT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically significant improvements in sexual desire scores and reductions in related distress compared to placebo.

Human trial data exist for sexual function in both women and men, including some with erectile dysfunction unresponsive to PDE5 inhibitors, but no published human trials specifically examine PT-141 in SSRI users.

## Selank Evidence

Selank is a synthetic heptapeptide with reported anxiolytic effects in Russian clinical studies. A 2008 randomized comparison in 62 patients with generalized anxiety disorder and neurasthenia found efficacy comparable to medazepam on Hamilton Anxiety Rating Scale and other measures, without sedation, cognitive impairment, or withdrawal.

Additional Russian trials (e.g., 30–70 patients) reported similar anxiolytic benefits and cognitive enhancement versus benzodiazepines. Selank is approved in Russia for anxiety disorders. No large-scale Western RCTs or data specific to SSRI breakthrough anxiety or combination use exist.

## Mechanisms (Mechanistic Tier)

PT-141 acts centrally via melanocortin receptors to modulate arousal signaling independent of vascular pathways.

Selank influences GABA-A receptor subunit expression and shows non-benzodiazepine anxiolytic activity in preclinical and limited human transcriptomic studies.

## Combination and SSRI Context

No human data, preclinical studies, or user reports in indexed sources address the PT-141 + Selank combination or its use specifically for SSRI-induced sexual dysfunction and anxiety. Any application remains speculative.

## Evidence Summary

- PT-141: Human (FDA approval and phase 3 trials for HSDD).
- Selank: Human (Russian clinical trials for GAD; limited Western validation).
- SSRI-specific effects or stack: Speculative (no supporting data).

---

Related:
[Selank](/a/selank) · [PT-141](/a/pt-141)

[[embed:selank]]

[[embed:pt-141]]

## Sources

1. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder — https://pmc.ncbi.nlm.nih.gov/articles/PMC6819021/
2. VYLEESI Prescribing Information — https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf
3. Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic and Dopaminergic Neurotransmission — https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/
4. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia — https://www.researchgate.net/publication/299052506_Efficacy_and_possible_mechanisms_of_action_of_a_new_peptide_anxiolytic_selank_in_the_therapy_of_generalized_anxiety_disorders_and_neurasthenia
5. Bremelanotide: Uses, Interactions, Mechanism of Action — https://go.drugbank.com/drugs/DB11653
6. Selank peptides, Can you take it with escitaloprám. — https://www.reddit.com/r/PeptideForum/comments/1mo483x/selank_peptides_can_you_take_it_with_escitalopr%C3%A1m/
7. Anyone taking Semax and Selank. What is your experience — https://www.reddit.com/r/PeptideForum/comments/1qjtdfv/anyone_taking_semax_and_selank_what_is_your/
8. Full PT-141 Guide — https://www.reddit.com/r/BodyHackGuide/comments/1qt7vsg/full_pt141_guide/
9. PT-141 - Peptide Affect — https://peptideaffect.com/pt-141/
10. Peptides With Psychiatric Medications: A Psychiatrists Guide — https://thebh.us/blog/peptides-with-psychiatric-medications/
11. Has anyone tried PT-141, selank, or semax? — https://www.reddit.com/r/PeptideDiscussion/comments/1ra5gba/has_anyone_tried_pt141_selank_or_semax/
12. Love Potion (PT141-Selank-Oxytocin) nasal spray — https://glp1forum.com/threads/love-potion-pt141-selank-oxytocin-nasal-spray.18608/